Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.
Institute of Radiology and Nuclear Medicine, Cantonal Hospital Baselland, Liestal, Switzerland.
Eur Radiol. 2023 Mar;33(3):1884-1894. doi: 10.1007/s00330-022-09187-3. Epub 2022 Oct 25.
The main aim of the present systematic review was a comprehensive overview of the Radiomics Quality Score (RQS)-based systematic reviews to highlight common issues and challenges of radiomics research application and evaluate the relationship between RQS and review features.
The literature search was performed on multiple medical literature archives according to PRISMA guidelines for systematic reviews that reported radiomic quality assessment through the RQS. Reported scores were converted to a 0-100% scale. The Mann-Whitney and Kruskal-Wallis tests were used to compare RQS scores and review features.
The literature research yielded 345 articles, from which 44 systematic reviews were finally included in the analysis. Overall, the median of RQS was 21.00% (IQR = 11.50). No significant differences of RQS were observed in subgroup analyses according to targets (oncological/not oncological target, neuroradiology/body imaging focus and one imaging technique/more than one imaging technique, characterization/prognosis/detection/other).
Our review did not reveal a significant difference of quality of radiomic articles reported in systematic reviews, divided in different subgroups. Furthermore, low overall methodological quality of radiomics research was found independent of specific application domains. While the RQS can serve as a reference tool to improve future study designs, future research should also be aimed at improving its reliability and developing new tools to meet an ever-evolving research space.
• Radiomics is a promising high-throughput method that may generate novel imaging biomarkers to improve clinical decision-making process, but it is an inherently complex analysis and often lacks reproducibility and generalizability. • The Radiomics Quality Score serves a necessary role as the de facto reference tool for assessing radiomics studies. • External auditing of radiomics studies, in addition to the standard peer-review process, is valuable to highlight common limitations and provide insights to improve future study designs and practical applicability of the radiomics models.
本系统综述的主要目的是全面概述基于 Radiomics Quality Score(RQS)的系统综述,以突出放射组学研究应用中的常见问题和挑战,并评估 RQS 与综述特征之间的关系。
根据系统综述的 PRISMA 指南,对多个医学文献档案进行文献检索,以报告通过 RQS 进行的放射组学质量评估。报告的评分转换为 0-100%的比例。使用 Mann-Whitney 和 Kruskal-Wallis 检验比较 RQS 评分和综述特征。
文献研究产生了 345 篇文章,最终有 44 篇系统综述被纳入分析。总体而言,RQS 的中位数为 21.00%(IQR=11.50)。根据目标(肿瘤/非肿瘤目标、神经放射学/身体成像焦点和一种成像技术/多种成像技术、特征描述/预后/检测/其他)进行亚组分析时,RQS 没有显著差异。
我们的综述没有发现报告的系统综述中放射组学文章的质量存在显著差异,这些文章分为不同的亚组。此外,无论特定的应用领域如何,放射组学研究的整体方法学质量都较低。虽然 RQS 可以作为改进未来研究设计的参考工具,但未来的研究还应旨在提高其可靠性并开发新的工具,以满足不断发展的研究领域的需求。
放射组学是一种很有前途的高通量方法,可以生成新的成像生物标志物来改善临床决策过程,但它是一种固有复杂的分析方法,通常缺乏可重复性和通用性。
Radiomics Quality Score 是评估放射组学研究的必要参考工具。
除了标准的同行评审过程外,对放射组学研究进行外部审核对于突出常见的局限性和提供见解以改进未来的研究设计和放射组学模型的实际适用性非常有价值。